$RILY

B. Riley Financial (NASDAQ:RILY) Issues Quarterly Earnings Results

B. Riley Financial (NASDAQ:RILY) recently reported quarterly EPS of $0.77, causing shares to drop by 6.1% to $3.72, with the company currently holding a market cap of $113.82 million and a negative P/E of -0.15. The stock has a consensus "Sell" rating, reinforced by a "sell (e+)" rating from Weiss Ratings in December. Institutional investors currently own about 50.20% of the shares, with several, including Russell Investments and Federated Hermes, increasing their stakes.

Original reporting
MarketBeat · MarketBeat
Published Dec 16, 2025, 11:09 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Dec 16, 2025, 11:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
B. Riley Financial (NASDAQ:RILY) Issues Quarterly Earnings Results — source image
Decision brief

The 30-second read

$RILYBearishLow
01

Why it matters

The earnings miss and bearish ratings suggest continued pressure, but the company's fundamentals and potential catalysts should be monitored for signs of reversal.

02

Market read

The news has immediate relevance for traders holding or considering RILY and related financial stocks, especially in the small-cap segment.

03

What to watch

Possible upcoming catalysts such as strategic initiatives or sector-wide recovery signals that could reverse current negative trends.

Timing: short-term

Background

B. Riley Financial's recent earnings report indicates a disappointing quarter, with negative analyst sentiment and declining stock price.

Company-level read

Ticker impact

$RILYBearishHigh confidence
Context

High relevance as the news directly pertains to the company's earnings and stock performance.

Expected impact

Likely continued downward pressure in the short term; potential for further declines if negative sentiment persists.

Evidence & confidence

The earnings miss and negative analyst ratings strongly suggest ongoing weakness, especially given the recent price decline and bearish outlook.

Market effects

Negative sentiment may influence the financial services and investment sectors, especially small-cap stocks.

Limited regional impact; primarily affects US-based financial stocks.

Minimal global relevance due to company size and market cap.

Counterpoint

Some investors may view the decline as an overreaction and consider buying on dips, anticipating a potential rebound if broader market conditions improve.

Key entities

  • B. Riley Financial

    A financial services company providing investment banking, trading, and brokerage services.

Related articles

$RILYMed

BRC Group Holdings, Inc. (RILY): Results of Operations and Financial Condition

BRC Group Holdings, Inc. (RILY) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE BRC Group Holdings, Inc. Reports Second Quarter 2026 Financial Results Second Quarter 2026 Net Income Available to Common Shareholders of $18.5 Million; Second Quarter 2026 Adjusted EBITDA of $61.3 Million; Operating Adjusted EBITDA of $66.0 Million LOS ANGE

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.

$WMTMedAI 8/10

Walmart to Build $1.3 Billion Fulfillment Center in Georgia

Walmart plans to build a $1.3 billion automated fulfillment center in Carnesville, Georgia, creating 1,000 jobs and expanding shipping capacity. The 1.5 million-square-foot facility is part of Walmart's strategy to meet evolving customer expectations for speed and convenience. Construction is expected to begin in late 2026.